Acurx Pharmaceuticals is undervalued, with promising market potential for its lead antibiotic, ibezapolstat. Find out why ...

a non-viral approach to genetically modify CAR-T cells. Shedding the CAR-T projects means Merck can concentrate on the development of its PD-L1 inhibitor Bavencio (avelumab) – partnered with ...

Merck in Germany was possibly the earliest company ... pharma companies have taken the idea one step further and have been able to genetically modify the patient’s own cells to fight cancer.

International science and technology firm Merck has announced investment of over £4 million in its Life Science facility in Livingston, bringing new jobs to the town. The investment in ...

Belen Garijo took charge of German drug-to-semiconductor group Merck KGaA with the tailwind of the Covid pandemic, propelling the stock to an all-time high in 2021. Since then, the shares have ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other most promising low-cost stocks. The September Consumer Price Index data showed that consumer ...

Merck (MRK) reachead $106.64 at the closing of the latest trading day, reflecting a +0.28% change compared to its last close. Visa, Netflix, Merck and Hovnanian are included in this Analyst Blog ...

Barclays analyst Carter Gould maintained a Buy rating on Merck & Company (MRK – Research Report) today and set a price target of $140.00. The company’s shares closed yesterday at $109.75.

Merck KGaA said it’s seeing the beginning of a post-Covid pandemic rebound in life sciences as it reaffirmed the group’s sales and profit guidance for the full year. The German science and ...

(RTTNews) - Merck & Co., Inc. (MRK) announced the positive results from the Phase 2b/3 clinical trial (MK-1654-004) evaluating clesrovimab, the company's investigational prophylactic monoclonal ...

On Oct. 1 and 2, the American Chemical Society held its 21st annual Pharma Leaders Conference, hosted this year at the Merck & Co. campus in Rahway, New Jersey. Leaders in medicinal chemistry from ...